Brooklyn Investment Group Has $134,000 Position in Waters Co. (NYSE:WAT)

Brooklyn Investment Group raised its holdings in Waters Co. (NYSE:WAT) by 28.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 362 shares of the medical instruments supplier’s stock after acquiring an additional 80 shares during the quarter. Brooklyn Investment Group’s holdings in Waters were worth $134,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in WAT. Itau Unibanco Holding S.A. acquired a new stake in shares of Waters in the 2nd quarter valued at $33,000. Kennebec Savings Bank bought a new position in Waters during the third quarter valued at about $33,000. Ashton Thomas Securities LLC bought a new position in Waters during the third quarter valued at about $35,000. Fortitude Family Office LLC lifted its position in shares of Waters by 235.7% in the fourth quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier’s stock worth $35,000 after buying an additional 66 shares during the last quarter. Finally, Federated Hermes Inc. bought a new stake in shares of Waters during the 2nd quarter worth about $59,000. 94.01% of the stock is owned by institutional investors.

Waters Stock Performance

Shares of NYSE WAT opened at $403.85 on Friday. The firm has a market capitalization of $23.98 billion, a price-to-earnings ratio of 38.54, a PEG ratio of 6.66 and a beta of 1.01. The company has a current ratio of 2.02, a quick ratio of 1.38 and a debt-to-equity ratio of 1.14. The business has a fifty day simple moving average of $378.42 and a 200 day simple moving average of $350.18. Waters Co. has a one year low of $279.24 and a one year high of $411.58.

Waters (NYSE:WAT) last released its quarterly earnings data on Friday, November 1st. The medical instruments supplier reported $2.93 earnings per share for the quarter, beating the consensus estimate of $2.68 by $0.25. The company had revenue of $740.30 million for the quarter, compared to analyst estimates of $712.99 million. Waters had a return on equity of 49.93% and a net margin of 21.43%. The company’s revenue was up 4.0% compared to the same quarter last year. During the same period in the prior year, the company posted $2.84 EPS. Sell-side analysts expect that Waters Co. will post 11.79 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on WAT shares. Cfra set a $389.00 target price on Waters in a report on Thursday, October 17th. Jefferies Financial Group upgraded shares of Waters from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $355.00 to $415.00 in a research note on Tuesday, October 8th. Bank of America raised their target price on shares of Waters from $400.00 to $430.00 and gave the company a “neutral” rating in a research note on Friday, December 13th. Barclays upped their price target on shares of Waters from $330.00 to $360.00 and gave the company an “underweight” rating in a report on Monday, November 4th. Finally, Stifel Nicolaus lifted their price objective on Waters from $332.00 to $360.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $384.71.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.